AVEO Oncology
AVEO
#7099
Rank
HK$4.05 B
Marketcap
HK$116.77
Share price
0.00%
Change (1 day)
170.86%
Change (1 year)

Earnings for AVEO Oncology (AVEO)

Earnings in 2022 (TTM): -HK$0.23 Billion

According to AVEO Oncology 's latest financial reports the company's current earnings are HK$94.31 Million. In 2021 the company made an earning of -HK$0.42 Billion a decrease over its 2020 earnings that were of -HK$0.28 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AVEO Oncology from 2009 to 2022

Annual earnings

Year Earnings Change
2022 (TTM) -HK$0.23 Billion-45.24%
2021 -HK$0.42 Billion49.9%
2020 -HK$0.28 Billion-479.04%
2019 HK$73.08 M-276.17%
2018 -HK$41.49 Million-91.79%
2017 -HK$0.51 Billion142.38%
2016 -HK$0.21 Billion78.51%
2015 -HK$0.12 Billion-71.55%
2014 -HK$0.42 Billion-50.72%
2013 -HK$0.84 Billion-4.88%
2012 -HK$0.88 Billion-426.29%
2011 HK$0.26 B-159.85%
2010 -HK$0.45 Billion35.33%
2009 -HK$0.34 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Biogen
BIIB
HK$14.82 B-6,656.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
HK$40.05 B-17,817.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
-HK$17.59 Million-92.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$62.53 B-27,762.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$175.18 B-77,594.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$64.17 B-28,489.41%๐Ÿ‡บ๐Ÿ‡ธ USA